XZC-16883-08759
2 vaccinations
1 coded response
25 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 799 / TX
- Registered
- 2022-01-19
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-19
Registered in v-safe
-
2022-01-19
Dose 1 — Pfizer-BioNTech
- 2022-01-19
-
2022-01-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-21
- 2022-01-22
- 2022-01-23
- 2022-01-24
- 2022-01-25
- 2022-01-26
- 2022-02-02
-
2022-02-09
Dose 2 — Pfizer-BioNTech
- 2022-02-09
-
2022-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-02-11
- 2022-02-12
- 2022-02-13
- 2022-02-14
- 2022-02-15
- 2022-02-16
- 2022-02-25
- 2022-03-02
- 2022-03-09
- 2022-03-16
- 2022-03-23
- 2022-05-11
- 2022-08-10
-
2023-02-09
Survey response — 12 months, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-19 | Pfizer-BioNTech | No |
| 2 | 2022-02-09 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release